I found a patent for this recently while performing a literature search.
commons.wikimedia.org
It is a BAT substrate with triple reuptake inhibitor properties.
“Its inhibiting effect is near to that of the imipramine as far as NA, 5-HT and choline are concerned, but is very superior to that of imipramine concerning the uptake of the dopamine at the level of the striatum."
The patent title claims that the compound may have use in treating depression as well as Parkinson’s syndrome.
File:3,4-Diphenylquinuclidine.svg - Wikimedia Commons
It is a BAT substrate with triple reuptake inhibitor properties.
“Its inhibiting effect is near to that of the imipramine as far as NA, 5-HT and choline are concerned, but is very superior to that of imipramine concerning the uptake of the dopamine at the level of the striatum."
The patent title claims that the compound may have use in treating depression as well as Parkinson’s syndrome.